转录激活因子6:潜在的抗2型糖尿病药物新靶点

来源 :药学进展 | 被引量 : 0次 | 上传用户:tt77uu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
真核细胞中的内质网是蛋白质合成、翻译和转运的场所,当内质网稳态被打破,出现蛋白质折叠障碍或错误折叠,并导致蛋白质过度积累时,便会引发内质网应激反应,即未折叠蛋白反应。大量的研究表明,内质网应激与2型糖尿病的病理特征有一定的关系,而转录激活因子6通路作为未折叠蛋白反应中3条信号通路之一,调控着蛋白质的重折叠过程,对缓解内质网应激以及在糖脂代谢和胰岛素敏感性方面起着重要作用。简介内质网应激反应及相关信号通路和转录激活因子6,着重综述转录激活因子6在肝脏糖脂代谢和胰岛素抵抗中的作用及相应机制,探讨其成为抗2型糖尿病药物新靶点的可能性,为抗2型糖尿病药物的研发提供新思路。 The endoplasmic reticulum in eukaryotes is where proteins are synthesized, translated, and transported. Endoplasmic reticulum stress is triggered when the homeostasis of the endoplasmic reticulum is broken, protein folding disorders or misfolding occur, and protein over-accumulation occurs The reaction, ie the unfolded protein reaction. A large number of studies have shown that endoplasmic reticulum stress has a certain relationship with the pathological features of type 2 diabetes. The transcriptional activator 6 pathway, as one of the 3 signaling pathways in the unfolded protein, regulates protein refolding. Relieve endoplasmic reticulum stress and play an important role in glycolipid metabolism and insulin sensitivity. Introduction Endoplasmic reticulum stress response and related signal pathways and transcriptional activators 6, focusing on the role of transcriptional activator 6 in liver glucose and lipid metabolism and insulin resistance and its corresponding mechanisms, to explore its become a new target of anti-type 2 diabetes drug Possibility of providing new ideas for the development of anti-type 2 diabetes drugs.
其他文献
会议
该年度报告涉及2013年最新上市的56种新药及生物制品,包括20种新孤儿药和10种全新药物,以及获得美国FDA“新突破药物”称号的前3名药物.此外,该年度报告还讨论了30种重要的延
汤森路透Newport PremiumTM数据库收集来自全球仿制药市场的可靠信息,为制造企业在寻找评估新产品项目,以及制定企业发展战略的过程中提供权威的分析数据。汤森路透借助该数
c-Met为一种由原癌基因MET编码的跨膜受体酪氨酸激酶,是肝细胞生长因子的受体,与多种癌症的不良预后有关。近年来,c-Met抑制剂作为一种对抗癌症的有效策略备受关注。结合汤森
Cystic hepatic neoplasms are rare tumors,and are classified into two separate entities:mucinous cystic neoplasms(MCNs)and intraductal papillary mucinous neoplas
会议